Bymaster FP et al (2002) Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder. Neuropsychopharmacology 27(5):699-711 Chamberlain SR et al (2006) Neurochemical modulation of response inhibition and probabilistic learning in humans. Science 311 (5762):861-863

Chamberlain SR et al (2007) Atomoxetine improved response inhibition in adults with attention deficit/hyperactivity disorder. Biol Psychiatry 62:977-984

Chamberlain SR et al (2009) Atomoxetine modulates right inferior frontal activation during inhibitory control: a pharmacological functional magnetic resonance imaging study. Biol Psychiatry 65(7):550-555 Cheng JY et al (2007) Efficacy and safety of atomoxetine for attention-deficit/hyperactivity disorder in children and adolescents-meta-analysis and meta-regression analysis. Psychopharmacology (Berl) 194(2):197-209

Cottrell S et al (2008) A modeled economic evaluation comparing ato-moxetine with stimulant therapy in the treatment of children with attention-deficit/hyperactivity disorder in the United Kingdom. Value Health 11(3):376-388 Faraone SVet al (2005) Efficacy of atomoxetine in adult attention-deficit/ hyperactivity disorder: a drug-placebo response curve analysis. Behav Brain Funct 1:16 Robinson ES et al (2008) Similar effects of the selective noradrenaline reuptake inhibitor atomoxetine on three distinct forms of impulsiv-ity in the rat. Neuropsychopharmacology 33(5):1028-1037 Sauer JM, Ring BJ, Witcher JW (2005) Clinical pharmacokinetics of atomoxetine. Clin Pharmacokinet 44(6):571-590 Spencer T et al (1998) Effectiveness and tolerability of tomoxetine in adults with attention deficit hyperactivity disorder. Am J Psychiatry 155(5):693-695

Trzepacz PT et al (2008) CYP2D6 metabolizer status and atomoxetine dosing in children and adolescents with ADHD. Eur Neuropsycho-pharmacol 18(2):79-86 Virani A (2005) Perspectives in psychopharmacology: spotlight on ato-

moxetine. Can Child Adolesc Psychiatr Rev 14(4):96-98 Wee S, Woolverton WL (2004) Evaluation of the reinforcing effects of atomoxetine in monkeys: comparison to methylphenidate and de-sipramine. Drug Alcohol Depend 75(3):271-276

Understanding And Treating ADHD

Understanding And Treating ADHD

Attention Deficit Disorder or ADD is a very complicated, and time and again misinterpreted, disorder. Its beginning is physiological, but it can have a multitude of consequences that come alongside with it. That apart, what is the differentiation between ADHD and ADD ADHD is the abbreviated form of Attention Deficit Hyperactive Disorder, its major indications being noticeable hyperactivity and impulsivity.

Get My Free Ebook

Post a comment